TFF Pharmaceuticals (TFFP) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

TFF Pharmaceuticals Revenue Highlights


Latest Revenue (Y)

$733.87K

Latest Revenue (Q)

$193.39K

TFF Pharmaceuticals Revenue by Period


TFF Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$733.87K100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2017-12-31--

TFF Pharmaceuticals generated $733.87K in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

TFF Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$193.39K-70.26%
2024-06-30$650.22K219.88%
2024-03-31$203.27K-72.30%
2023-12-31$733.87K100.00%
2023-09-30--100.00%
2023-06-30$333.35K548.18%
2023-03-31$51.43K100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-09-30--

TFF Pharmaceuticals generated $193.39K in revenue during Q3 2024, up -70.26% compared to the previous quarter, and up 58.01% compared to the same period a year ago.

TFF Pharmaceuticals Revenue Breakdown


TFF Pharmaceuticals Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 24
Grant$87.34K

TFF Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Grant (100.00%).

TFF Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TCRXTScan Therapeutics$21.05M-
IMNMImmunome$14.02M$2.91M
CUECue Biopharma$5.49M$3.34M
TFFPTFF Pharmaceuticals$733.87K$193.39K
ANIXAnixa Biosciences$210.00K-
GANXGain Therapeutics$55.18K-
ANEBAnebulo Pharmaceuticals--
ANTXAN2 Therapeutics--
INABIN8bio--
CGTXCognition Therapeutics--
DRMADermata Therapeutics--
ANVSAnnovis Bio--
LTRNLantern Pharma--
QNRXQuoin Pharmaceuticals--
INMBINmune Bio$-155.00K-

TFFP Revenue FAQ


What is TFF Pharmaceuticals’s yearly revenue?

TFF Pharmaceuticals's yearly revenue for 2023 was $733.87K, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TFFP's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is TFF Pharmaceuticals’s quarterly revenue?

TFF Pharmaceuticals's quarterly revenue for Q3 2024 was $193.39K, a -70.26% decrease from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $650.22K, a 219.88% increase from the previous quarter (Q1 2024), and a 95.06% increase year-over-year (Q2 2023). TFFP's quarterly revenue for Q1 2024 was $203.27K, a -72.30% decrease from the previous quarter (Q4 2023), and a 295.25% increase year-over-year (Q1 2023).

What is TFF Pharmaceuticals’s revenue growth rate?

TFF Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.